The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys

The ongoing coronavirus disease 2019 (COVID-19) pandemic has caused disruption in all aspects of daily life, including the management and treatment of rare inherited metabolic disorders (IMDs). To perform a preliminary assessment of the incidence of COVID-19 in IMD patients and the impact of the cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lampe, C., Dionisi-Vici, C., Bellettato, C. M., Paneghetti, L., van Lingen, C., Bond, S., Brown, C., Finglas, A., Francisco, R., Sestini, S., Heard, J. M., Scarpa, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711270/
https://www.ncbi.nlm.nih.gov/pubmed/33272301
http://dx.doi.org/10.1186/s13023-020-01619-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711270/
https://www.ncbi.nlm.nih.gov/pubmed/33272301
http://dx.doi.org/10.1186/s13023-020-01619-x

Ejemplares similares